| Advances in Auto-Segmentation |
29 |
| Adaptive Radiotherapy for Anatomical to Changes |
24 |
| Robust Proton Treatment Planning: Physical and Biological Optimization |
23 |
| Clinical Trial Strategies to Compare Protons With Photons |
17 |
| Deformable Registration for Dose Accumulation |
15 |
| Role of Immunotherapy in Head and Neck Cancer |
15 |
| The Role of Optical Surface Imaging Systems in Radiation Therapy |
14 |
| Exercise as Adjunct Therapy in Cancer |
14 |
| Use of PET and Other Functional Imaging to Guide Target Delineation in Radiation Oncology |
14 |
| Heavy Charged Particles: Does Improved Precision and Higher Biological Effectiveness Translate to Better Outcome in Patients? |
13 |
| Head and Neck Cancer Survivorship: Learning the Needs, Meeting the Needs |
13 |
| Proton Therapy for Head and Neck Cancers |
13 |
| Practical Clinical Workflows for Online and Offline Adaptive Radiation Therapy |
12 |
| Automated Radiotherapy Treatment Planning |
11 |
| Radiation-Induced Liver Disease and Modern Radiotherapy |
11 |
| Head and Neck Cancer Adaptive Radiation Therapy (ART): Conceptual Considerations for the Informed Clinician |
10 |
| Radiotherapy for Hepatocellular Carcinoma |
10 |
| Targeting Cancer Stem Cell Redox Metabolism to Enhance Therapy Responses |
9 |
| Targeting NAD(+) Metabolism to Enhance Radiation Therapy Responses |
8 |
| Magnetic Resonance Imaging for Target Delineation and Daily Treatment Modification |
8 |
| Stereotactic Ablative Radiotherapy Uncertainties: Delineation, Setup and Motion |
8 |
| Management of Nodal Disease in Advanced Cervical Cancer |
7 |
| See, Think, and Act: Real-Time Adaptive Radiotherapy |
7 |
| Pharmacological Ascorbate as a Means of Sensitizing Cancer Cells to Radio Chemotherapy While Protecting Normal Tissue |
7 |
| Utilizing Superoxide Dismutase Mimetics to Enhance Radiation Therapy Response While Protecting Normal Tissues |
7 |
| A Contemporary Update on the Role of Stereotactic Body Radiation Therapy (SBRT) for Liver Metastases in the Evolving Landscape of Oligometastatic Disease Management |
7 |
| Comparing Intensity-Modulated Proton Therapy With Intensity-Modulated Photon Therapy for Oropharyngeal Cancer: The Journey From Clinical Trial Concept to Activation |
6 |
| Potential Morbidity Reduction With Proton Radiation Therapy for Breast Cancer |
6 |
| Image-guided Adaptive Radiotherapy in Cervical Cancer |
6 |
| Relative Biological Effectiveness Uncertainties and Implications for Beam Arrangements and Dose Constraints in Proton Therapy |
6 |
| Current Status and Future Directions of Treatment Deintensification in Human Papilloma Virus-associated Oropharyngeal Squamous Cell Carcinoma |
6 |
| Molecular Imaging-Guided Radiotherapy for the Treatment of Head-and-Neck Squamous Cell Carcinoma: Does it Fulfill the Promises? |
6 |
| Concepts of PTV and Robustness in Passively Scattered and Pencil Beam Scanning Proton Therapy |
5 |
| Can Technological Improvements Reduce the Cost of Proton Radiation Therapy? |
5 |
| Protons vs Photons for Brain and Skull Base Tumors |
5 |
| Big Data From Small Devices: The Future of Smartphones in Oncology |
4 |
| Proton Beam Therapy and Carbon Ion Radiotherapy for Hepatocellular Carcinoma |
4 |
| Evolving Systemic Therapy in Hepatocellular Carcinoma: Current Management and Opportunities for Integration With Radiotherapy |
4 |
| Emerging Opportunities for Digital PET/CT to Advance Locoregional Therapy in Head and Neck Cancer |
4 |
| Pathologic Evaluation and Prognostic Implications of Nodal Micrometastases in Breast Cancer |
3 |
| Regional Radiation Therapy for Oropharyngeal Cancer in the HPV Era |
3 |
| The Evolving and Multidisciplinary Considerations in Nodal Radiation in Breast Cancer |
3 |
| Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: Imaging for Diagnosis, Tumor Response to Treatment and Liver Response to Radiation |
3 |
| Current State of Image Guidance in Radiation Oncology: Implications for PTV Margin Expansion and Adaptive Therapy |
3 |
| Manipulation of Glucose and Hydroperoxide Metabolism to Improve Radiation Response |
3 |
| Utilization of Vitamin E Analogs to Protect Normal Tissues While Enhancing Antitumor Effects |
3 |
| Accounting for, Mitigating, and Choice of Margins for Moving Tumors |
3 |
| The Evolving Use of Electronic Health Records (EHR) for Research |
3 |
| Use of Big Data for Quality Assurance in Radiation Therapy |
3 |
| Cholangiocarcinoma and Gallbladder Cases: An Expert Panel Case-Based Discussion |
2 |
